Contact Us marketing@medicilon.com
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
SERVICES
SERVICES
01 Drug Discovery
Chemistry Research Biology Research Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates Active Pharmaceutical Ingredients Pharmaceutical preparation Analytical Method Development and Quality Control CMC Filings Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics Drug Safety Evaluation DMPK Bioanalysis IND Filings
PLATFORM
PLATFORM
01 One-stop Integrated Services
Liposome Drug Development Drug Discovery Pharmaceutical Research Preclinical Research Botanical Drug Preclinical R&D
02 Innovative Drug R&D Services
Peptide Drug Conjugate (PDC) Antibody Nucleic Acid Drug Cellular Immunotherapies mRNA Vaccine PROTAC ADC
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection Metabolite Identification (MetID) Drug Forming Research Flow Cytometry Technology SEND Format Conversion Flow Sorting NanoString nCounter Detection Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Inflammatory and Immune Diseases IO Pharmacodynamic Model
05 High-end Preparations Technology Platform
Skin Topical Preparation Ophthalmic drug Inhalation drug
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service KRAS-targeted Drugs R&D Service GLP-1 New Drug R&D Service
07 Safety Assessment Lab of Process Chemistry

08 Public Services
CAREERS
Talent Development
Campus Recruitment
Recruitment
NEWS
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
INVESTORS
Stock Information
Investment Contact
CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
CN
×
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Sep 15,2015
cGMP Trigger for Cell Signaling By Optogenetic Fungal Protein
Cyclic GMP (cGMP) signaling regulates multiple biological functions through activation of protein kinase G and cyclic nucleotide-gated (CNG) channels. In sensory neurons, cGMP permits signal modulation, amplification and encoding, before depolarization. The optogenetic toolbox keeps expanding. Besides containing light-sensitive proteins that can be used to adjust membrane potential, protein-protein interactions, and gene expression, the optogeneticRead more
More
Sep 15,2015
Broadly Neutralizing Antibody Can Pin HIV with Either of Dual Holds
    An antibody is a large, Y-shape protein produced by plasma cells that is used by the immune system to identify and neutralize pathogens such as bacteria and viruses.   Even broadly neutralizing antibodies (bNAbs) have difficulty grappling with HIV, but one such antibody has shown that it can prevent HIV from slipping away. This particular bNAb,Read more
More
Broadly Neutralizing Antibody Can Pin HIV with Either of Dual Holds
Sep 14,2015
Researchers Decipher Mechanism Linking Periodontitis and Heart Disease
Scientists say they have shown that a periodontal pathogen causes changes in gene expression that boost inflammation and atherosclerosis in aortic smooth muscle cells, thus raising the risk of a heart attack. The research ("Gingipains from the periodontal pathogen Porphyromonas gingivalis play a significant role in regulation of Angiopoietin 1 and Angiopoietin 2 in humanRead more
More
Researchers Decipher Mechanism Linking Periodontitis and Heart Disease
Sep 14,2015
Dengue Hemorrhagic Shock Protein Identified, Shows Potential as Vaccine
    Dengue fever, also known as breakbone fever, is a mosquito-borne tropical disease caused by the dengue virus.  If you've made it to the end of the summer with no mosquito bites, consider yourself lucky. There are many places in the world where these vexatious insects carry debilitating diseases that can not only adversely affect individuals,Read more
More
Sep 14,2015
Last week brought the first U.S. launch in a new category called “biosimilars.”
Years after discounted versions of some of the most expensive drugs ever went on sale in other countries, they’re finally coming to the world’s biggest medicine market. Last week brought the first U.S. launch in a new category called “biosimilars.” They’re near-copies of powerful prescription drugs known as biologics “manufactured” in living cells. Biologics areRead more
More
Sep 11,2015
Possible Evidence for Person-to-Person Transmission of Alzheimer's Pathology
Prions are the misshapen proteins that replicate by inducing normal proteins to misfold and aggregate in the brain, leading to rare diseases such as mad cow and kuru. In recent years, scientists have discovered that similar processes of protein misfolding are at work in many neurodegenerative disorders, including Alzheimer's, Parkinson's and Lou Gehrig's disease.
More
Possible Evidence for Person-to-Person Transmission of Alzheimer's Pathology
Sep 11,2015
Scientists Developed Novel Cell-Free Protein Synthesis Platform
    Cell-free protein synthesis (CFPS) represents an alternative to cell-based expression as it dramatically improves the development of engineered proteins.  Scientists from Northwestern University and Yale say they have developed a user-friendly technology to help scientists understand how proteins work and fix them when they are broken. They believe such knowledge could pave the way forRead more
More
Scientists Developed Novel Cell-Free Protein Synthesis Platform
Sep 10,2015
Takeda to Collaborate with Gencia to Co-Develop MAGR Drugs
    Takeda Pharmaceutical will collaborate with Gencia to co-develop its new class of small molecule drugs as drug candidates for hematological and inflammatory diseases, in a collaboration that could generate more than $500 million for Gencia.  
More
Takeda to Collaborate with Gencia to Co-Develop MAGR Drugs
Sep 10,2015
MRSA Vaccine Close to Reality
    NYU Langone Medical Center's scientist team says they have found out why a particular strain of Staphylococcus aureus, known as HA-MRSA, becomes more deadly than other variations. The new findings open up possible new pathways to vaccine development against this bacterium, which the Centers for Disease Control and Prevention says accounts for over 10,000 deathsRead more
More
Sep 09,2015
Stem Cell Differentiation Being Regulated by New Method
    Scientists at the University of Helsinki in Finland say they have developed a new method that enables the activation of genes in a cell without changing the genome. Applications of the method include directing the differentiation of stem cells.     The method was developed by researchers Diego Balboa and Jere Weltner, who are working on theirRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->